— Know what they know.
Not Investment Advice

ACUT OTC

Accustem Sciences Inc.
1W: +12.5% 1M: -15.6% 3M: -52.7% YTD: -83.4% 1Y: -91.0% 3Y: -86.5%
$0.14
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 36 · $2.2M mcap · 10M float · 0.040% daily turnover · Short 65% of daily vol

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2022-04-05
Earliest Filing
2022-04-05
Latest Filing
acquirer: 1 target: 1

Counterparties (Filed by ACUT)

2 relationships

Companies named in ACUT's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
AccuStem Sciences Inc. ACUT acquirer Issuer of common stock in a purchase agreement 2022-04-05 View
Tiziana Life Sciences Ltd. TLSA target Purchaser of common stock in a purchase agreement 2022-04-05 View
Recent 8-K Filings (12)
Filing Date Description Type SEC
2025-11-26 Other Events View
2025-01-02 Changes in Registrant's Certifying Accountant View
2024-12-30 Changes in Registrant's Certifying Accountant View
2024-04-10 Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits View
2023-06-09 Departure/Election of Directors; Appointment of Officers View
2023-06-07 Regulation FD Disclosure; Financial Statements and Exhibits View
2022-11-16 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2022-10-14 Submission of Matters to a Vote of Security Holders View
2022-06-21 Departure/Election of Directors; Appointment of Officers View
2022-04-05 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Departure/Electio Agreement View
2022-03-10 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2021-12-03 Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregi Agreement Acquisition View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms